Trial
NCT03720483
Inhaled NAC in Treatment of IPF
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Intervention
N-acetyl cysteine then Placebo
Why stopped
The study encountered challenges during startup due to the COVID-19 epidemic and was withdrawn.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-08